Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $1.687B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 975,000 | $120M | 7.1% | $120.07 | -1.8% | SHS USD | G50871105 |
| CYTK | Cytokinetics Inc | 2,350,000 | $111M | 6.6% | $67.54 | -23.1% | COM NEW | 23282W605 |
| MRK | Merck & Co Inc | 800,000 | $79.58M | 4.7% | $98.70 | 0.0% | COM | 58933Y105 |
| ASND | Ascendis Pharma A/S | 520,000 | $71.59M | 4.2% | $133.54 | — | SPONSORED ADR | 04351P101 |
| RARE | Ultragenyx Pharmaceutical Inc | 1,500,000 | $63.1M | 3.7% | $46.29 | +7.2% | COM | 90400D108 |
| INSM | Insmed Inc | 900,000 | $62.14M | 3.7% | $51.36 | +40.2% | COM PAR $.01 | 457669307 |
| BMRN | BioMarin Pharmaceutical Inc | 860,000 | $56.53M | 3.4% | $74.71 | -10.3% | COM | 09061G101 |
| QURE | uniQure NV | 3,025,000 | $53.42M | 3.2% | $6.46 | +33.6% | SHS | N90064101 |
| SLNO | Soleno Therapeutics Inc | 1,060,000 | $47.65M | 2.8% | $35.94 | +44.2% | COM | 834203309 |
| NUVL | Nuvalent Inc | 600,000 | $46.97M | 2.8% | $93.39 | 0.0% | COM | 670703107 |
| GPCR | Structure Therapeutics Inc | 1,725,000 | $46.78M | 2.8% | $36.80 | — | SPONSORED ADS | 86366E106 |
| VERA | Vera Therapeutics Inc | 1,075,000 | $45.46M | 2.7% | $44.28 | 0.0% | CL A | 92337R101 |
| IMTX | Immatics NV | 6,275,000 | $44.62M | 2.6% | $9.89 | -13.1% | SHS | N44445109 |
| KALV | KalVista Pharmaceuticals Inc | 4,770,000 | $40.4M | 2.4% | $12.01 | -13.8% | COM | 483497103 |
| GERN | Geron Corp | 11,000,000 | $38.94M | 2.3% | $4.05 | -1.3% | COM | 374163103 |
| — | Astria Therapeutics Inc | 4,180,000 | $37.37M | 2.2% | $10.75 | — | COM | 04635X102 |
| ACLX | Arcellx Inc | 475,000 | $36.43M | 2.2% | $54.07 | +59.8% | COMMON STOCK | 03940C100 |
| SNY | Sanofi SA | 750,000 | $36.17M | 2.1% | $50.11 | — | SPONSORED ADR | 80105N105 |
| GSK | GSK PLC | 1,000,000 | $33.82M | 2.0% | $35.94 | — | SPONSORED ADR | 37733W204 |
| SVRA | Savara Inc | 10,775,000 | $33.08M | 2.0% | $4.20 | -17.1% | COM | 805111101 |
| XENE | Xenon Pharmaceuticals Inc | 810,000 | $31.75M | 1.9% | $40.76 | +1.4% | COM | 98420N105 |
| FOLD | Amicus Therapeutics Inc | 3,350,000 | $31.56M | 1.9% | $10.39 | 0.0% | COM | 03152W109 |
| AZN | AstraZeneca PLC | 475,000 | $31.12M | 1.8% | $65.52 | — | SPONSORED ADR | 046353108 |
| SRPT | Sarepta Therapeutics Inc | 250,000 | $30.4M | 1.8% | $122.55 | 0.0% | COM | 803607100 |
| MDGL | Madrigal Pharmaceuticals Inc | 95,000 | $29.31M | 1.7% | $273.23 | +2.9% | COM | 558868105 |
| GMED | Globus Medical Inc | 325,000 | $26.88M | 1.6% | $78.87 | 0.0% | CL A | 379577208 |
| DNTH | Dianthus Therapeutics Inc | 1,075,000 | $23.43M | 1.4% | $23.57 | +9.1% | COM | 252828108 |
| NYXH | Nyxoah SA | 2,924,216 | $23.39M | 1.4% | $8.73 | 0.0% | SHS | B6S7WD106 |
| — | Verona Pharma PLC | 495,000 | $22.99M | 1.4% | $46.44 | — | SPONSORED ADS | 925050106 |
| IONS | Ionis Pharmaceuticals Inc | 595,000 | $20.8M | 1.2% | $37.38 | 0.0% | COM | 462222100 |
| LQDA | Liquidia Corp | 1,760,000 | $20.7M | 1.2% | $10.54 | +3.7% | COM NEW | 53635D202 |
| DAWN | Day One Biopharmaceuticals Inc | 1,440,000 | $18.24M | 1.1% | $14.45 | -3.7% | COM | 23954D109 |
| URGN | UroGen Pharma Ltd | 1,630,000 | $17.36M | 1.0% | $12.68 | -5.6% | COM | M96088105 |
| LEGN | Legend Biotech Corp | 475,000 | $15.46M | 0.9% | $36.80 | — | SPONSORED ADS | 52490G102 |
| ROIV | Roivant Sciences Ltd | 1,250,000 | $14.79M | 0.9% | $11.82 | 0.0% | SHS | G76279101 |
| REGN | Regeneron Pharmaceuticals Inc | 20,000 | $14.25M | 0.8% | $834.60 | 0.0% | COM | 75886F107 |
| ESTA | Establishment Labs Holdings In | 300,000 | $13.82M | 0.8% | $43.57 | +0.0% | COM | G31249108 |
| TYRA | Tyra Biosciences Inc | 990,000 | $13.76M | 0.8% | $18.15 | 0.0% | COM | 90240B106 |
| BCAX | Bicara Therapeutics Inc | 710,000 | $12.37M | 0.7% | $23.62 | -11.9% | COM | 055477103 |
| BDTX | Black Diamond Therapeutics Inc | 5,600,000 | $11.98M | 0.7% | $5.15 | -44.4% | COM | 09203E105 |
| SLDB | Solid Biosciences Inc | 2,850,000 | $11.4M | 0.7% | $8.93 | -38.5% | COM NEW | 83422E204 |
| A | Agilent Technologies Inc | 75,000 | $10.08M | 0.6% | $135.59 | +0.2% | COM | 00846U101 |
| — | Applied Therapeutics Inc | 11,500,000 | $9.846M | 0.6% | $1.17 | — | COM | 03828A101 |
| PRGO | Perrigo Co PLC | 375,000 | $9.641M | 0.6% | $26.27 | 0.0% | SHS | G97822103 |
| NRIX | Nurix Therapeutics Inc | 485,000 | $9.137M | 0.5% | $16.48 | +39.1% | COM | 67080M103 |
| LXEO | Lexeo Therapeutics Inc | 1,200,000 | $7.896M | 0.5% | $12.73 | -38.1% | COM | 52886X107 |
| ZLAB | Zai Lab Ltd | 300,000 | $7.857M | 0.5% | $26.19 | — | ADR | 98887Q104 |
| CLDX | Celldex Therapeutics Inc | 305,000 | $7.707M | 0.5% | $27.17 | 0.0% | COM NEW | 15117B202 |
| VYGR | Voyager Therapeutics Inc | 1,230,000 | $6.974M | 0.4% | $7.12 | — | COM | 92915B106 |
| — | iTeos Therapeutics Inc | 900,000 | $6.912M | 0.4% | $14.84 | — | COM | 46565G104 |
| NTLA | Intellia Therapeutics Inc | 525,000 | $6.122M | 0.4% | $15.61 | 0.0% | COM | 45826J105 |
| OKUR | OnKure Therapeutics Inc | 635,000 | $5.461M | 0.3% | $15.14 | 0.0% | COM CL A | 68277Q105 |
| GLPG | Galapagos NV | 180,000 | $4.95M | 0.3% | $36.24 | — | SPON ADR | 36315X101 |
| — | Chimerix Inc | 1,400,000 | $4.872M | 0.3% | $0.96 | — | COM | 16934W106 |
| — | Sutro Biopharma Inc | 2,570,000 | $4.729M | 0.3% | $1.84 | — | COM | 869367102 |
| VTYX | Ventyx Biosciences Inc | 2,000,000 | $4.38M | 0.3% | $3.51 | -35.5% | COM | 92332V107 |
| FATE | Fate Therapeutics Inc | 2,465,000 | $4.067M | 0.2% | $3.24 | -22.2% | COM | 31189P102 |
| ANRO | Alto Neuroscience Inc | 915,000 | $3.87M | 0.2% | $11.75 | -46.9% | COM SHS | 02157Q109 |
| — | Verve Therapeutics Inc | 645,000 | $3.638M | 0.2% | $5.02 | — | COM | 92539P101 |
| — | Passage Bio Inc | 6,100,000 | $3.459M | 0.2% | $1.21 | — | COM | 702712100 |
| ALLO | Allogene Therapeutics Inc | 1,500,000 | $3.195M | 0.2% | $3.70 | -33.3% | COM | 019770106 |
| TMDX | TransMedics Group Inc | 50,000 | $3.118M | 0.2% | $93.08 | 0.0% | COM | 89377M109 |
| GLUE | Monte Rosa Therapeutics Inc | 425,000 | $2.95M | 0.2% | $5.10 | +47.2% | COM | 61225M102 |
| ZYME | Zymeworks Inc | 185,000 | $2.708M | 0.2% | $9.47 | +47.7% | COM | 98985Y108 |
| ENGN | Engene Holdings Inc | 370,000 | $2.461M | 0.1% | $7.77 | 0.0% | COM | 29286M105 |
| BHC | Bausch Health Cos Inc | 250,000 | $2.015M | 0.1% | $8.24 | 0.0% | COM | 071734107 |
| NGNE | Neurogene Inc | 80,000 | $1.829M | 0.1% | $37.21 | 0.0% | COM | 64135M105 |
| — | Achilles Therapeutics PLC | 1,500,000 | $1.71M | 0.1% | $1.22 | — | SPONSORED ADS | 00449L102 |
| ATRA | Atara Biotherapeutics Inc | 125,000 | $1.664M | 0.1% | $14.38 | -26.7% | COM NEW | 046513206 |
| IMVT | Immunovant Inc | 45,000 | $1.115M | 0.1% | $28.37 | 0.0% | COM | 45258J102 |
| MGNX | MacroGenics Inc | 280,000 | $910K | 0.1% | $14.22 | -74.7% | COM | 556099109 |
| TRAW | Traws Pharma Inc | 75,000 | $666K | 0.0% | $5.57 | 0.0% | COM NEW | 68232V884 |
| TENX | Tenax Therapeutics Inc | 55,189 | $342K | 0.0% | $3.62 | +34.0% | COM NEW | 88032L605 |